Our long-form value communications are focused on meeting the needs of your most demanding external stakeholders. Whether it is a peer-reviewed manuscript, access evidence dossier or the clinical section of a regulatory submission, we can support your communication requirement. What sets us apart is that our documents are written by scientists – our clinical scientists, physicians, outcomes researchers and epidemiologists - of course, with editorial support from our dedicated medical writing team.
To further enhance your internal and external evidence communication, we develop bespoke, interactive evidence dashboards which convey evidence in an intuitive format that a broad audience will find easy to grasp and draw insights from.
Click for information on our evidence dashboards
Here is a selection of high-impact publications that have resulted from projects we have undertaken for different clients.
Ferrier, G., Filipovic, A., Wasan, H. et al. A targeted literature review on the impact of tailored interventions on patient outcomes in oncology. Oncogene (2025). https://doi.org/10.1038/s41388-025-03424-x
Vukusic S, Bove R, Dobson R, et al. Pregnancy and Infant Outcomes in Women With Multiple Sclerosis Treated With Ocrelizumab. Neurol Neuroimmunol Neuroinflamm. 2025;12(1):e200349. doi:10.1212/NXI.0000000000200349
Gish R, Agarwal K, Mahajan A, Desai S, Kharawala S, Elston R, Das J, Kendrick S, Gielen V. Nucleos(t)ide Analog Treatment Discontinuation in Chronic Hepatitis B Virus Infection: A Systematic Literature Review. Gastro Hep Advances. Published online December 2024.
Mahajan A, Kharawala S, Desai S, Kendrick S, Das J, Gielen V. Association of Hepatitis B Surface Antigen Levels With Long-Term Complications in Chronic Hepatitis B Virus Infection: A Systematic Literature Review. J Viral Hepat. Published online August 16, 2024.
Kokaliaris C, Evans R, Hawkins N, et al. Long-Term Comparative Efficacy and Safety of Risdiplam and Nusinersen in Children with Type 1 Spinal Muscular Atrophy. Adv Ther. Published online May 5, 2024.
Chase DM, Mahajan A, Scott DA, Hawkins N, Kalilani L. The impact of varying levels of residual disease following cytoreductive surgery on survival outcomes in patients with ovarian cancer: a meta-analysis. BMC Womens Health. 2024;24(1):179
Chase DM, Mahajan A, Scott DA, Hawkins N, Kalilani L. Correlation between progression-free survival and overall survival in patients with ovarian cancer after cytoreductive surgery: a systematic literature review. Int J Gynecol Cancer. 2023;33(10):1602-1611
